Jan 8, 2016 - Inventor(s). Flower Mound, TX 75028 / US. [2007/30]. Chapman, Paul Gilmour, et al. Marks & Clerk LLP. Representative(s). Atholl Exchange.
Espacenet - Bibliographic data
j
Page 1 of 1
'","P''''''' PlItf'I1IJlTlt Eot,,~!'ai')
Patent oence Off![eeurnpeen des brtv~h
Espacenet
~i~!i~_9r.~_p~i~data: EP1490502(~2)-
2004-12-29
SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER
Inventor(s):
SIRBASKU DAVID A [US].±. (SIRBASKU, DAVID A)
Applicant(s):
SIRBASKU DAVID A [US].±. (SIRBASKU, DAVID A, ; SIGNE BIOPHARMA INC)
Classification:
• international:A61K311138; A61K3114188; A61K311437; A61K311453; A61K311566; A61K311568; C12Q1168; G01N331574; (IPC1-7): A61 K39/395; C12Q1/00 • cooperative: A61K31/138; A61K31/4188; A61K31/437; A61K31/453; A61K31/566; A61K31/568; C12Q1I6886; C12Q2600/106 EP2002078066420021113
Application number: Priority number (s):
W02002US36542 20021113 ; US20010332920P 20011114
Also published as:
EP1490502 (A4) EP1490502 (B1) W003042660 (A2) W003042660 (A3) AU2002343704 (A1)
Abstract not available for EP1490502 (A2) Abstract of corresponding document: W003042660 (A2)
A method to aid in identifying a familial or sporadic pattern of risk in at least one individual for developing cancer of a mucosal epithelial tissue, the method comprising screening said at least one individual for heterozygosity or homozygosity for a mutation in a gene coding for a Poly-Ig (Fe) receptor or a Poly-lg-Iike (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor. A method of treating an individual so identified includes enhancing the amount of immunoglobulin inhibitor contacting a mucosal epithelial tissue of said individual, and, especially in individuals homozygous for the defective receptor, may also include prophylactic surgery. Other methods include implementation of a risk reduction or prevention program in individuals identified as being at risk.
http://worldwide.espacenet.com/publicationDetailslbiblio?CC=EP&NR=1490502&KC=&1...1/12/2016
About this file - European Patent Register
j
Page 1 of 4
turcpatsches P,ltentodmt EuropeaFl
Patent OffIce Office european des brevets
Extract from the Register of European Patents
About this file: EP1490502 EP1490502 - SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER [Right-click to bookmark this link] Status
Most recent event
Applicant(s)
No opposition filed within time limit Database last updated on 08.01.2016 03.07.2015
Lapse of the patent in a contracting state New state(s): TR
published on 05.08.2015 [2015/32]
For all designated states Signe BioPharma Inc. 1717 W Walnut Hill Lane, Suite 104 Irving TX 75038/ US [2013/02]
Inventor(s)
01 / Sirbasku, David A. 1413 Basil Drive Flower Mound, TX 75028 / US [2007/30]
Representative(s)
Chapman, Paul Gilmour, et al Marks & Clerk LLP Atholl Exchange 6 Canning Street Edinburgh EH3 8EG / GB [2013/42] 02780664.5
Application number, filing date
13.11.2002
[2005/01] W02002US36542
Priority number, date
US20010332920P
14.11.2001 Original published format: US 332920 P
[2005/01] Filing language
EN
Procedural language
EN
Publication
Type:
A2 Application without search report
No.:
W003042660
Date:
22.05.2003
Language:
EN
[2003/21] Type:
A2 Al;1l;1lication without search rel;1ort
No.:
EP1490502
Date:
29.12.2004
Language:
EN
The application has been published by WIPO in one of the EPO official languages on 22.05.2003 [2005/01]
https:llregister.epo.org/application?number=EP02780664&tab=main
1112/2016
About this file - European Patent Register
Type:
Page 2 of4
B1 Patent sl2ecification
No.:
EP1490502
Date:
09.01.2013
Language:
EN
[2013/02] International search report • published on:
US
15.01.2004
Supplementary European search report • EP dispatched on:
17.05.2005
Classification
International:
[2012/08]
Designated contracting states
AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2005/01]
International and Supplementary search report(s)
Title
German:
SCREENING· VERFAHREN ZUR VORHERSAGE DER ANFALLlGKEIT FOR BRUSTKREBS
[2005/01]
English:
SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER
[2005/01]
French:
METHODE DE DEPISTAGE PERMETIANT D'EVALUER UNE [2005/01] PREDISPOSITION AU CANCER DU SEIN
01.10.2004
National basic fee paid
01.10.2004
Search fee paid
01.10.2004
Designation feels) paid
01.10.2004
Examination fee paid
01.10.2004
Examination requested [2004/53]
07.03.2006
Despatch of a communication from the examining division (Time limit: M06)
15.09.2006
Reply to a communication from the examining division
13.12.2006
Despatch of a communication from the examining division (Time limit: M06)
14.06.2007
Reply to a communication from the examining division
08.11.2007
Despatch of a communication from the examining division (Time limit: M04)
18.03.2008
Reply to a communication from the examining division
01.07.2008
Despatch of a communication from the examining division (Time limit: M06)
09.04.2009
Reply to a communication from the examining division
19.05.2009
Despatch of a communication from the examining division (Time limit: M06)
05.01.2010
Despatch of communication that the application is deemed to be withdrawn,
Entry into regional phase
Examination procedure
C12Q1/68
https:llregister.epo.org/application?number=EP02780664&tab=main
1/12/2016
About this file - European Patent Register
Page 3 of 4
reason: reply to the communication from the examining division not received in time 12.03.2010
Reply to a communication from the examining division
20.09.2011
Cancellation of oral proceeding that was planned for 21.09.2011
21.09.2011
Date of oral proceedings (cancelled)
26.09.2011
Despatch of a communication from the examining division (Time limit: M02)
05.12.2011
Reply to a communication from the examining division
28.03.2012
Communication of intention to grant the patent
03.08.2012
Fee for grant paid
03.08.2012
Fee for publishing/printing paid
Divisional application(s)
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.03.2006
Opposition(s)
10.10.2013
No opposition filed within time limit [2013/51)
The application is deemed to be withdrawn due to failure to reply to the examination report .....
Request for further processing for:
Fees paid
09.04.2009
Request for further processing filed
09.04.2009
Full payment received (date of receipt of payment) Request granted
27.04.2009
Decision despatched
I'
......
...
Renewal fee 25.01.2005
Renewal fee patent year 03
14.11.2005
Renewal fee patent year 04
14.11.2006
Renewal fee patent year 05
15.11.2007
Renewal fee patent year 06
31.03.2008
Renewal fee patent year 07
12.11.2009
Renewal fee patent year 08
12.11.2010
Renewal fee patent year 09
28.09.2011
Renewal fee patent year 10
13.11.2012
Renewal fee patent year 11
Penalty fee Penalty fee Rule 85a EPC 1973 21.07.2004
AT M02 Fee paid on 01.10.2004
21.07.2004
BE M02 Fee paid on 01.10.2004
21.07.2004
BG M02 Fee paid on 01.10.2004
21.07.2004
CH M02 Fee paid on 01.10.2004
21.07.2004
CY M02 Fee paid on 01.10.2004
21.07.2004
CZ M02 Fee paid on 01.10.2004
21.07.2004
DE M02 Fee paid on 01.10.2004
21.07.2004
OK M02 Fee paid on 01.10.2004
21.07.2004
EE M02 Fee paid on 01.10.2004
21.07.2004
ES M02 Fee paid on 01.10.2004
21.07.2004
FI M02 Fee paid on 01.10.2004
21.07.2004
FR M02 Fee paid on 01.10.2004
21.07.2004
GB M02 Fee paid on 01.10.2004
21.07.2004
GR M02 Fee paid on 01.10.2004
21.07.2004
IE M02 Fee paid on 01.10.2004
21.07.2004
IT M02 Fee paid on 01.10.2004
https:llregister,epo.org/application?number=EP02780664&tab=main
111212016
9IOllZ1I1
'gv£OL0600dX 'ez-s~sa6ed '( ro -~0-966~) 966~ AJenuer ~ '~ 'ou 'u '1011 'XX 'XX 'Cl30N'v'0 ~ S3""OSO""OClHO 'S3N38 '"SISAl'v'N'v' d1.:!CIaN'v' 3.L1ll3.L'v'SINI"" 'I 'Cl30N'v'0 .LS'v'3C18N'v'""nH NI ~ 3""OSO""OClHO NO 30N'v'l'v'8""1 011311'v'":1'v'.L3 1 "" .LCI'v'dnOl 06v9£~OOM['v'] ggZZ9~OOM['v') gv9ZHOOM['v') ~96L690d3['v'] o ~Zgg~OOM[dX) LO£99 ~OOM[dX)
s
4!>Jea
[Wg~OZ) £~OZ'90'60
.Ld
£~OZ'VO'OZ
S3
£~OZ'vO'O~
Cl8
£~OZ'VO'60
88
£~onO'60
CI.L
£~onO'60
)fS
£~onO'60
0""
uoujsoddo 6u!Jnp sasde1
£~OZ'~O'60
.LI
£~onO'60
I.:!
£~onO'60
33
£~OZ'~O'60
)fa
£~OZ'~O'60
ZO
£~onO'60
AO
£~OZ'~O'60
38
£~OZ'~O'60
.L'v'
900Z' ~O'9Z uo Pied aa.:! gO"" £0
r---------------------~
vOOZ'~~'O£
aaJleMauaJJOJaaJleuompp'v' vOOZ'O~'~O uo Pied aa.:! ZO""
vOOZ'LO'~Z £L6 ~ Od3 qgg alnClaaJ};lleuad
vOOZ'O~'~Ouo Pied aa.:! ZO"" CI.L VOOZ'O~'~Ouo Pied aa.:! ZO"" )fS
vOOZ'LO'~Z
vOOZ'O~'~Ouo Pied aa.:! ZO"" 3S VOOZ'O~'~Ouo Pied aa.:! ZO"" .Ld
vOOZ'LO'~Z
VOOZ'O~'~Ouo Pied aa.:! ZO"" 1N VOOZ'O~'~Ouo Pied aa.:! ZO"" 0"" -oozorro uo Pied aa.:! ZO""
vOOZ'LO'~Z
rn
vOOZ'LO'~Z
vOOZ'LO'~Z
vOOZ'LO'~Z vOOZ'LO'~Z
Intellectual Property Office - Patent document and information service (Ipsum)
Page 1 of2
1_ Intellectual Property Office ._. '.,
Ipsum - Online Patent Information and Document Inspection Service EP1490502 - Screening method for predicting susceptibility
to breast cancer
Case Details Application Number
EP02780664.5
Application Source
European
Publication Number
EP1490502
Publication Language
English
Status
Ceased
Filing Date
13 November 2002
Publication Date
29 December 2004
Grant Date
Patent granted with effect from 09 January 2013 (Section 25(1})
Last Renewal Date
13 November 2013
Year of Last Renewal
12
Next Renewal Date
13 November 2014
Not In Force Date
13 November 2014
PCT Application Number PCT/US20021036542 PCT Publication Number W02003/042660 (Dated 22 May 2003) Priority Claimed
14 November 2001 in United States of America - Document: 332920P
Designated States
AT BE BG CH CY CZ DE OK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Application Title
Screening method for predicting susceptibility to breast cancer
Grant Title
Screening method for predicting susceptibility to breast cancer
Address for Service
MARKS & CLERK LLP Aurora 120 Bothwell Street GLASGOW G27JS United Kingdom [ADP Number 09973520001)
Applicant I Proprietor
SIGNE BIOPHARMA INC. 1717 WWalnut Hill Lane, Suite 104 Irving TX 75038 United States of America [ADP Number 77196855001)
Inventor
DAVID A. SIRBASKU 1413 Basil Drive Flower Mound, TX 75028 United States of America [ADP Number 77196863001]
EPO Representative
PAUL GILMOUR CHAPMAN Marks & Clerk LLP Aurora
https:llwww.ipo.gov.uklp-ipsum/CaselPublicationNumber/EPI490502
12/0112016
Intellectual Property Office - Patent document and information service (Ipsum)
Page 2 of2
120 Bothwell Street Glasgow G27JS United Kingdom [ADP Number 70044359001]
• © Crown Copyright 2016 • Intellectual Property Office is an operating name of the Patent Office
https://wwwjpo.gov.uk/p-ipsurn/CaselPubIicationNumberIEP1490502
12/0112016
